13ᵗʰ International Symposium on Hodgkin Lymphoma
back to
back to
  • Program
    • Schedule
    • 26.10.2024
    • 27.10.2024
    • 28.10.2024
    • Scientific Committee
  • Media
    • Photos
    • Videos
    • Downloads
    • Abstracts
  • Newsletters
  • Acknowledgements
  • Sponsors
  • Other Archives
    • ISHL13
    • ISHL12
    • Update on Hodgkin Lymphoma
    • ISHL11
    • ISHL10
    • ISHL9
    • ISHL8
    • ISHL7
Back to video list

Molecular and microenvironmental vulnerabilities of B-cell lymphomas

Speaker

Sirpa Leppä

Session

EHA-LYG / GHSG Joint Educational “Emerging Therapeutic Concepts in B-Cell Lymphomas”

Others Talks of this Session

  • Introduction
  • Is there a role for CAR T-cell therapy in first-line Tx of indolent lymphoma?
  • Who needs bispecific antibodies as first-line treatment in aggressive lymphoma?
  • How to implement novel ADCs in the first-line treatment of lymphoma
  • Perspectives of small molecule based first-line therapy of LBCL
  • Treatment and Trial Landscape for Malignant Lymphoma in China

Quicklink

  1. Program
  2. General
  3. Sponsors
  4. Contact
  5. Partners
  1. Abstracts
  2. Downloads
  3. Legal Info
  4. Archive
  5. Privacy Policy

How to contact us

German Hodgkin Study Group (GHSG)
University Hospital of Cologne

Kerpener Str. 62
D-50924 Köln

info@hodgkinsymposium.org

This website uses cookies to ensure you get the best experience on our website. By using our site you agree to our use of cookies. Learn more